This content is machine translated Cancer Management Oncological interventions at the cutting edge of knowledge The latest findings in the field of cancer research were again presented at the ASCO Annual Meeting in Chicago. Experts discussed innovative treatment methods, new therapies and current controversies in…
View Post 4 min This content is machine translated Gastrointestinal tumors Latest scientific findings from stomach to colon Themed “Applying Innovation, Transforming Care, Advancing Equity,” ASCO-GI celebrated its 20th anniversary this year. The focus this year was primarily on current findings relating to gastric carcinoma. However, further studies…
View Post 6 min This content is machine translated Head and neck tumors New prognostic models and biomarkers in focus of development Malignant tumors in the head and/or neck area always pose challenges for experts. Immunotherapy can now be used to treat a wide range of cancers, but the response rate often…
View Post 4 min This content is machine translated Breast Cancer New predictors of survival probability detected Breast cancer is as heterogeneous as the patients affected. The forecast varies accordingly. Several analyses have now examined the impact of, for example, autoimmune diseases or socioeconomic status on overall…
View Post 3 min This content is machine translated Test procedure Breast cancer early detection using biomarkers – where do we stand? Early detection of breast cancer still offers the best chance of cure. Mammography is the benchmark for screening, but is subject to technical, logistical, and diagnostic limitations. For this reason,…
View Post 11 min This content is machine translated ASCO 2018 in Chicago Study news on lung, kidney and intestine KEYNOTE-042 and CARMENA: Two studies that have the potential to change practice. It’s about lung cancer – as so often lately – but also about renal cell carcinoma. Furthermore, the…
View Post 8 min This content is machine translated ASCO 2017 in Chicago Groundbreaking on tumors of the prostate and gallbladder There was big news at the 2017 ASCO Congress. First, abiraterone is pushing into the first-line setting in metastatic prostate cancer. On the other hand, there is a new standard…
View Post 5 min This content is machine translated ASCO Congress in Chicago Modern drugs and digital media improve cancer therapy This year’s ASCO Congress theme was “Collective Wisdom: The Future of Patient-Centered Care and Research.” According to ASCO, in order to continue to make progress in the care and treatment…
View Post 2 min This content is machine translated Breast Cancer Therapy Strategies to maintain bone health Adjuvant endocrine therapy for breast cancer has adverse effects on bone health. Possible consequences are treatment-induced osteopenia, osteoporosis and fractures. It is known that antiresorptive substances such as bisphosphonates counteract…
View Post 2 min This content is machine translated Follow-up of the NeoSphere study Compelling data on the neoadjuvant use of pertuzumab NeoSphere is a phase II trial in which 417 women with newly diagnosed HER2-positive, operable, locally advanced or inflammatory early breast cancer were randomized to four different neoadjuvant therapy arms.…
View Post 5 min This content is machine translated Stomach cancer, endometrial carcinoma, sarcomas New study results from the ASCO Congress 2015 In June 2015, the Swiss PostASCO Meeting took place in Bern – the ideal event for all those who cannot or do not want to attend the ASCO Congress in…
